125 related articles for article (PubMed ID: 16536761)
1. Limited significance of routine excretory urography in the follow-up of patients with superficial bladder cancer after transurethral resection.
Miyake H; Hara I; Yamanaka K; Inoue TA; Fujisawa M
BJU Int; 2006 Apr; 97(4):720-3. PubMed ID: 16536761
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
3. The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer.
Meissner C; Giannarini G; Schumacher MC; Thoeny H; Studer UE; Burkhard FC
J Urol; 2007 Dec; 178(6):2287-90. PubMed ID: 17936846
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
Schulze M; Stotz N; Rassweiler J
J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
[TBL] [Abstract][Full Text] [Related]
5. Intravenous urography for diagnosing synchronous upper-tract tumours in patients with newly diagnosed bladder carcinoma can be restricted to patients with high-risk superficial disease.
Bajaj A; Sokhi H; Rajesh A
Clin Radiol; 2007 Sep; 62(9):854-7. PubMed ID: 17662732
[TBL] [Abstract][Full Text] [Related]
6. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
7. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
8. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
Herr HW
J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
[TBL] [Abstract][Full Text] [Related]
9. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
10. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of superficial bladder cancer recurring after initial transurethral resection].
Nakata S; Nakano K; Takahashi H; Shimizu K
Hinyokika Kiyo; 2005 Apr; 51(4):229-33. PubMed ID: 15912780
[TBL] [Abstract][Full Text] [Related]
12. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of bladder urothelial thickening and enhancement revealed on MDCT urography after transurethral resection of tumor.
Kim CS; Kim SH; Lee HJ; Kim YW
J Comput Assist Tomogr; 2012; 36(2):243-8. PubMed ID: 22446367
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
15. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey.
Yoshimura K; Utsunomiya N; Ichioka K; Matsui Y; Terai A; Arai Y
Urology; 2005 Feb; 65(2):290-4. PubMed ID: 15708040
[TBL] [Abstract][Full Text] [Related]
16. Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients.
Hurle R; Losa A; Manzetti A; Lembo A
Urology; 1999 Jun; 53(6):1144-8. PubMed ID: 10367843
[TBL] [Abstract][Full Text] [Related]
17. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin.
Baltacı S; Bozlu M; Yıldırım A; Gökçe Mİ; Tinay İ; Aslan G; Can C; Türkeri L; Kuyumcuoğlu U; Mungan A
BJU Int; 2015 Nov; 116(5):721-6. PubMed ID: 25715815
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in urine after transurethral resection of superficial bladder cancer and early recurrence.
Wu XX; Kakehi Y; Takahashi T; Habuchi T; Ogawa O
Int J Urol; 2000 Jun; 7(6):210-7. PubMed ID: 10843452
[TBL] [Abstract][Full Text] [Related]
19. MDCT urography for detecting recurrence after transurethral resection of bladder cancer: comparison of nephrographic phase with pyelographic phase.
Kim JY; Kim SH; Lee HJ; Kim MJ; Kim YH; Cho SH
AJR Am J Roentgenol; 2014 Nov; 203(5):1021-7. PubMed ID: 25341140
[TBL] [Abstract][Full Text] [Related]
20. Repeated transurethral resection and intravesical BCG for extensive superficial bladder tumors.
Ozen H; Ekici S; Uygur MC; Akbal C; Sahin A
J Endourol; 2001 Oct; 15(8):863-7. PubMed ID: 11724131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
